April 27, 2012
AstraZeneca CEO to retire amidst double digit losses
David Brennan's move to retire as AstraZeneca's (NYSE:AZN) CEO in June did not come as a…
April 26, 2012
National Bioeconomy Blueprint
“The world is shifting to an innovation economy and nobody does innovation better than America.”…
April 26, 2012
NATIONAL BIOECONOMY BLUEPRINT
“The world is shifting to an innovation economy and nobody does innovation better than America.”…
April 26, 2012
Drug research: All together now | The Economist
IT WAS once only drug firms that developed drugs. But this is changing. Take the…
April 26, 2012
Nodality loses leader to NEA as medical diagnostics model morphs – San Francisco Business Times
Growing diagnostic test developer Nodality Inc. is losing its first CEO, but the venture capital…
April 25, 2012
Zyngenia, Inc. Recruits David Parkinson, M.D., as Board Member, Clinical Advisory Board Head, and Interim Chief Medical Officer
Zyngenia, Inc., a biopharmaceutical company developing Zybodies(TM), next-generation multi-specific antibody-based drugs in oncology and immunology,…
